HOME >> BIOLOGY >> NEWS
HIV-Positive Injection Drug Users Often Don't Receive Protease Inhibitors And May Not Be Aware Of The Drug

GENEVA, Switzerland--A significant number of injection drug users in San Francisco who are HIV-positive do not receive protease inhibitors and may not even be aware of these medications--despite a commitment on the part of the city to make these drugs widely available.

"We found a lot of drug users were not taking the therapies, even though they were theoretically available to them. Many had not heard of the therapies, and some of them had heard of them but were still not taking them for whatever reasons," said Brian R. Edlin, MD, of the University of California San Francisco.

In a presentation here today (July 2) at the 12th World AIDS Conference, Edlin reported findings from a UCSF study on HIV therapy availability and adherence. Lead study investigator, he is a UCSF associate professor of health policy and community medicine and director of the UCSF Urban Health Study. Edlin noted that there is a bias against providing protease inhibitors, the powerful anti-HIV medications, to injection drug users because they are perceived as being poor adherers to treatment.

Nonetheless, the city has made it a policy to provide full access to these medications to all HIV-positive individuals. Federal guidelines also recommend that practitioners not discriminate in prescribing therapy on the basis of injection drug use, he said.

The UCSF research team set out to determine if, in fact, injection drug users were receiving the therapies.

Between October 1997 and March 1998, the research team interviewed 668 injection drug users in four San Francisco neighborhoods, testing them for HIV and questioning them about their knowledge of available HIV treatments. The researchers also conducted in-depth interviews with about a dozen individuals to help understand what factors might prevent or encourage those who were HIV-positive to adhere to combination therapy.

Sixty-three of the study participants (9.4 percent) were found to be HIV-positive.
'"/>

Contact: Corinna Kaarlela
corinna@irtsa.ucsf.edu
(415) 476-3804
University of California - San Francisco
2-Jul-1998


Page: 1 2 3

Related biology news :

1. Nationwide Study Finds HIV-Positive Women Are At High Risk For Cervical Human Papillomavirus Infection
2. Injection prevents blinding blood vessel growth in mice
3. Groundwater Injection Process Filters Out Contaminants
4. Bugscope Gives Internet Users Anywhere Chance To Study Insects
5. Hopkins Study Shows Brain Damage Evidence In "Ecstasy" Users
6. UF Researchers: Gene Therapy Replaces Critical Protein In Animal Model Of Often-Fatal Lung-Liver Disease
7. HIV Patients Often Experience Viral "Breakthrough," But May Still Remain Healthy, San Francisco Study Finds
8. Research Shows That If One Identical Twin Is Prey To Nightmares, Often The Other Is Too
9. Dont always believe what you see, suggests study on false memories
10. Dont drink the water: Texas A&M researcher conducting study of polluted Mexican lake
11. Dont ban embryo-based research says new chairman of European fertility organisation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... ... 18, 2018 , ... Protein derived from cottonseed for human ... , Writer: Kay Ledbetter, 806-677- 5608, skledbetter@ag.tamu.edu, Dr. Keerti Rathore, 979-862-4795, rathore@tamu.edu , ... to which Dr. Keerti Rathore has devoted more than half his professional career, ...
(Date:10/17/2018)... ... October 17, 2018 , ... Slone ... healthcare companies, proudly announces Insights: Scientific Healthcare Investing 2018, a panel discussion ... with co-producer Biocom, the association representing the life science industry of California, ...
(Date:10/16/2018)... ... 2018 , ... At five years old, Sam began having issues with his ... veterinarian found that he had arthritis in his lower, or lumbosacral, spine. At ... on supplements for the arthritis and monitored his activity. , Within two years, Sam ...
Breaking Biology News(10 mins):
(Date:10/11/2018)... ... October 11, 2018 , ... Umbilical cord ... leukemia, lymphoma, sickle cell anemia, among others, and the medical industry has been ... new e-book provides expert advice on ways to maintain the integrity and the ...
(Date:10/5/2018)... , ... October 04, 2018 , ... ... with genomics, along with Duke University, announced today at IDWeek™ 2018 the positive ... that detects pathogen DNA in plasma, accurately identified causative pathogens in patients with ...
(Date:10/3/2018)... ... October 03, 2018 , ... Milwaukee Area Technical College ... Wednesday, Oct. 17, from 3-7 p.m. in Room T129 in the T Building, 101 ... new CNC Swiss Lab. A ribbon cutting and formal program will be held at ...
(Date:10/2/2018)... ... October 02, 2018 , ... Contamination ... the reliability and reproducibility of experimental data. Each lab must consider whether ethanol ... webinar, which is sponsored by Eppendorf , attendees will learn how to ...
Breaking Biology Technology:
Cached News: